日本のバイオフォトニクス市場レポート：技法、技術、用途、地域別、2025年～2033年

日本のバイオフォトニクス市場規模は2024年に35億1,900万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに76億3,400万米ドルに達し、2025年から2033年にかけて9％の成長率（CAGR）を示すと予測しています。がんや神経疾患などの疾病の発生率の増加、精密診断ツールや標的治療に対するニーズの高まり、精密農業の重視の高まり、政府のイニシアティブや資金援助のエスカレート、医療の分散化やポイントオブケア検査へのシフトなどが、市場を推進する要因の一部です。

本レポートで扱う主な質問

• 日本のバイオフォトニクス市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本のバイオフォトニクス市場に与えた影響は？
• 日本のバイオフォトニクス市場の技法別区分は？
• 日本のバイオフォトニクス市場の技術別区分は？
• 日本のバイオフォトニクス市場の用途別区分は？
• 日本のバイオフォトニクス市場のバリューチェーンにおける各ステージとは？
• 日本のバイオフォトニクスの主要な促進要因と課題は？
• 日本のバイオフォトニクス市場の構造と主要プレーヤーは？
• 日本のバイオフォトニクス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本のバイオフォトニクス市場- イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本のバイオフォトニクス市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本のバイオフォトニクス市場- 技法別内訳

• 表面イメージング
• 分子分光法
• 顕微鏡検査
• 光療法
• バイオセンサー
• イメージングの内側
• シースルーイメージング
• その他

第7章 日本のバイオフォトニクス市場- 技術別内訳

• In-Vitro
• In-Vivo

第8章 日本のバイオフォトニクス市場- 用途別内訳

• 医療診断
• 医療治療
• 材料試験
• その他

第9章 日本のバイオフォトニクス市場- 競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本のバイオフォトニクス市場- 業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan biophotonics market size reached USD 3,519 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,634 Million by 2033, exhibiting a growth rate (CAGR) of 9% during 2025-2033. The increasing incidence of diseases such as cancer and neurological disorders, the rising need for precise diagnostic tools and targeted therapies, the growing emphasis on precision farming, the escalating government initiatives and funding support, and the shift towards decentralized healthcare and point-of-care testing are some of the factors propelling the market.

Biophotonics, an interdisciplinary field at the intersection of biology and photonics, explores the interaction between biological tissues and light. This emerging area of study encompasses a diverse range of technologies and techniques that leverage the unique properties of light to investigate, diagnose, and treat biological tissues at the molecular and cellular levels. It incorporates various optical methods, including fluorescence imaging, Raman spectroscopy, and optical coherence tomography, to capture and analyze the optical signatures of biological samples. The field has found application in diverse areas, such as medical diagnostics, neuroscience, and environmental monitoring. In medical contexts, biophotonics plays a pivotal role in non-invasive imaging techniques, enabling early disease detection and guiding minimally invasive surgical procedures. Additionally, it facilitates the study of cellular processes and interactions, shedding light on fundamental aspects of biology. The utilization of biophotonics is expanding rapidly, driven by advancements in imaging technologies, laser systems, and the development of novel optical probes. Furthermore, it contributes to the burgeoning field of theranostics, where diagnostics and therapy are integrated into a single approach. As biophotonics continues to evolve, it promises to revolutionize healthcare and biological research by providing powerful tools for visualization and manipulation at the microscopic and molecular scales, ultimately enhancing our understanding of living systems and improving diagnostic and therapeutic outcomes.

Japan Biophotonics Market Trends:

The market in Japan is majorly driven by the versatile applications and transformative potential across various industries. In line with this, the escalating demand for non-invasive diagnostic techniques in the medical field is significantly contributing to the market growth. Furthermore, biophotonics technologies, such as fluorescence imaging and optical coherence tomography, allow clinicians to visualize tissues at the cellular and molecular levels without requiring invasive procedures, enhancing diagnostic accuracy and early disease detection. This, in turn, is positively influencing the market. Besides, the rapid advancements in imaging technologies and the development of sophisticated optical probes contribute substantially to market expansion. Continuous innovations in laser systems, detectors, and imaging modalities enable more precise and sensitive detection, making biophotonics an increasingly indispensable tool in biological and medical research. Moreover, the growing prevalence of chronic diseases and the aging global population fuel the demand for advanced medical diagnostics and treatments. Biophotonics plays a crucial role in understanding the molecular basis of diseases, facilitating personalized medicine, and guiding targeted therapies, aligning with the broader trend of precision healthcare. In addition to healthcare, biophotonics is making significant inroads into other industries, such as agriculture and environmental monitoring. The ability of biophotonics to provide real-time, non-destructive analysis of biological materials has applications in quality control for food and agricultural products, as well as in monitoring environmental pollutants. The collaborative nature of biophotonics, bringing together expertise from photonics, biology, and medicine, fosters interdisciplinary research and development. This interdisciplinary approach fosters a dynamic ecosystem of innovation, driving the creation of new technologies and applications. Additionally, the heavy investments in research and development initiatives, both from the public and private sectors, are accelerating the pace of advancements in biophotonics. These investments not only support the refinement of existing technologies but also pave the way for the discovery of novel applications and the development of more cost-effective solutions. As the understanding of biophotonics continues to deepen and new applications emerge, the market is poised for sustained growth, offering transformative solutions that address complex challenges in healthcare, research, and various industries.

Japan Biophotonics Market Segmentation:

Technique Insights:

• Surface Imaging
• Molecular Spectroscopy
• Microscopy
• Light Therapy
• Biosensors
• Inside Imaging
• See-through Imaging
• Others

Technology Insights:

• In-Vitro
• In-Vivo

Application Insights:

• Medical Diagnostics
• Medical Therapeutics
• Material Testing
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan biophotonics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan biophotonics market?
• What is the breakup of the Japan biophotonics market on the basis of technique?
• What is the breakup of the Japan biophotonics market on the basis of technology?
• What is the breakup of the Japan biophotonics market on the basis of application?
• What are the various stages in the value chain of the Japan biophotonics market?
• What are the key driving factors and challenges in the Japan biophotonics?
• What is the structure of the Japan biophotonics market and who are the key players?
• What is the degree of competition in the Japan biophotonics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biophotonics Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Biophotonics Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Biophotonics Market - Breakup by Technique

• 6.1 Surface Imaging
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Molecular Spectroscopy
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Microscopy
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Light Therapy
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Biosensors
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)
• 6.6 Inside Imaging
  • 6.6.1 Overview
  • 6.6.2 Historical and Current Market Trends (2019-2024)
  • 6.6.3 Market Forecast (2025-2033)
• 6.7 See-through Imaging
  • 6.7.1 Overview
  • 6.7.2 Historical and Current Market Trends (2019-2024)
  • 6.7.3 Market Forecast (2025-2033)
• 6.8 Others
  • 6.8.1 Historical and Current Market Trends (2019-2024)
  • 6.8.2 Market Forecast (2025-2033)

7 Japan Biophotonics Market - Breakup by Technology

• 7.1 In-Vitro
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 In-Vivo
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Biophotonics Market - Breakup by Application

• 8.1 Medical Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Medical Therapeutics
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Material Testing
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Others
  • 8.4.1 Historical and Current Market Trends (2019-2024)
  • 8.4.2 Market Forecast (2025-2033)

9 Japan Biophotonics Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Biophotonics Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix